Skip to Content
scroll

CSL Limited (CSL)

ASX.CSL $277.90

20 MINUTE DELAYED

14 DAYS FREE ACCESS

Join Market Matters and get full access
to all our Opinion + Action

LEARN MORE

CSL $277.90

20 MINUTE DELAYED

TODAY

-0.75 %

1 YEAR RETURN

0.00%

VOLUME

421,764

DIV YIELD

1.36%

PE RATIO

36.61

52 WEEK RANGE

228.65

312.99

ANALYSIS

i

SHARE PRICE ACTIVITY
Last (Price)

277.90

Change

-2.10 (-0.75)

Bid / Ask

277.50 - 279.80

Volume

421,764

Turnover

117,599,300

Open

280.53

Day Range

277.90 - 281.98

VWAP

278.83

Prev Close

280.00

Last Trade

20/05 4:10pm (AEST)

i

KEY INFORMATION
Sector

Healthcare

Shares Issued

480,846,726

NTA/Share

0.00

Last Dividend

1.80

Dividend Ex Date

11 MAR 2024

Dividend Pay Date

03 APR 2024

i

BROKER CALLS

current

Mean

2.18

Target Price

0.00

BUY

i

CURRENT ()
Revenue

13,310.00

EBITDA

4,488.00

Profit

2,194.00

Earnings Per Share (EPS)

0

Dividend Per Share (DPS)

0

Yield %

1.36

Market Cap

0

Price to Earnings Ratio (P/E)

36.61

i

TARGET PRICE FORECAST

i

ESTIMATES ()
Revenue

14,711.78

EBITDA

4,898.72

Profit

2,877.50

Earnings Per Share (EPS)

6.00

Dividend Per Share (DPS)

2.65

i

BROKER CONSENSUS RECOMMENDATION

BUY

SELL

Target Price

0.00

Lt Growth Rate

0.00

Recommendation (BUY)

2.18
OPINION
ACTION
image description

Business Summary

CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical conditions live full lives. CSL is also involved in research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. CSL's operating model for its two businesses, CSL Behring and Seqirus.

Tagged video
WATCH
image description
Pulse Check Webinar: Opportunities in the unloved parts of the market Recorded Wednesday 27st September
image description

Only available to Members

Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required
For membership options and pricing. Click here
Back to top